Contact us

Business

Filters
Filters
Category
Search
Show (29)
Cancel
Emergent Bora announcement
Business

Bora Pharmaceuticals Expands North American Footprint with Agreement to Acquire First Sterile Manufacturing Facility

Bora Pharmaceuticals announced it entered into an agreement for Emergent BioSolutions’ sterile manufacturing facility in Baltimore-Camden, Maryland as part of
Presidential Innovation Award
Business

Bora Wins Presidential Innovation Award, Award Prize Donation to Benefit Those Impacted by Earthquake

The Office of the President Taiwan announced the winners of the 6th “Presidential Innovation” Award, and Bora Pharmaceuticals has been
Bora-USL3
Business

Bora Pharmaceuticals Completes the Acquisition of Upsher-Smith

Bora Pharmaceuticals announced it has completed the acquisition of Upsher-Smith Laboratories, a generics manufacturer and marketer based in Minnesota, USA.
SunWay and Gnosis by Lesaffre Form Alliance
Business

SunWay Biotech and Gnosis by Lesaffre Form Alliance to Launch MenaQ7® Metabolic, featuring the ANKASCIN® 568-R ingredient

SunWay Biotech and Gnosis by Lesaffre has announced a strategic partnership to launch their inaugural product, MenaQ7® Metabolic, featuring the
Upsher-Smith
Business

Bora Pharmaceuticals to Acquire US Pharma Manufacturer Upsher-Smith for $210 Million in Transaction to Fuel Global Expansion

Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), today announced that its Board of Directors has approved the
SunWay Biotech Day 1
Business

Bora Pharmaceuticals Celebrates Integration with SunWay Biotech, Embarking on a Global Journey

Taipei, Taiwan - December 11, 2023 – Last Friday, Bora Pharmaceuticals officially embraced SunWay Biotech into the Bora family.
Bobby Sheng and President Tsai Ing-wen
Business

Bora Recognized at “2023 Most Outstanding Company of the Year Awards.” Ceremony Attended by President Tsai Ing-wen

Bora Pharmaceuticals honored at the "2023 Most Outstanding Company of the Year Awards" ceremony with Taiwan’s President Tsai Ing-wen.
Taoyuan unveiling
Business

Bora Pharmaceuticals unveils eye-opening new facility for Ophthalmic manufacturing

Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market
9dab371d8d3507a5ed312a0f45bcb7dc
Business

Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market

Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market
image-missing
Business

Bora expands its CDMO capabilities as it makes landmark acquisition of TWi Pharmaceuticals

Establishing a lead position in Taiwan's CDMO sector

Bora

Contact

Address

  • 6F., No. 2, Aly. 36, Ln. 26, Ruiguang Rd., Neihu District, Taipei City, 114 Taiwan
Youtube Linkedin

Quick Links

Copyright © 2025 Bora Pharmaceuticals. Developed by Engage.